Chemoresistance, tumor progression, and metastasis are features that are frequently seen in cancer that have been associated with cancer stem cells (CSCs). These cells are a promising target in the future of cancer therapy but remain largely unknown. Deregulation of pathways that govern stemness in non-tumorigenic stem cells (SCs), such as Notch, Wnt, and Hedgehog pathways, has been described in CSC pathogenesis, but it is necessary to conduct further studies to discover potential new therapeutic targets. In addition, some markers for the identification and characterization of CSCs have been suggested, but the search for specific CSC markers in many cancer types is still under development. In addition, methods for CSC cultivation are also u...
Cancer stem cells are found in many cancer types. They comprise a distinct subpopulation of cells wi...
Cancer stem cells (CSCs) are gaining prominence in oncology. The characterization of the molecular p...
Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been considered ...
The Wnt, Hedgehog, and Notch pathways are inherent signaling pathways in normal embryogenesis, devel...
Cancer stem cells (CSCs) are self-renewable cell types that are identified in most types of liquid a...
Cells with "stemness" and tumor-initiating properties have been isolated from both hematological and...
Cancer stem cells (CSCs) have provided new insights into the tumorigenesis and metastatic potential ...
Cancer stem cells (CSCs) are thought to be a distinct population of cells within a tumor mass that a...
Resistance to cancer therapy remains a significant obstacle in treating patients with various solid ...
The cellular heterogeneity of neoplasms has been at the center of considerable interest since the "c...
Many theories have been proposed to explain the origins of cancer. Currently, evidences show that no...
Many, if not all, tumours contain a sub-population of self-renewing and expanding stem cells known a...
Abstract Cancer stem cells (CSCs) are defined as a subpopulation of malignant tumor cells with selec...
Cancer stem cells (CSCs) were discovered about 15 years ago in hematopoietic cancers. Subsequently, ...
Cancer stem cells (CSCs) with therapeutic resistance and plasticity can be found in various types of...
Cancer stem cells are found in many cancer types. They comprise a distinct subpopulation of cells wi...
Cancer stem cells (CSCs) are gaining prominence in oncology. The characterization of the molecular p...
Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been considered ...
The Wnt, Hedgehog, and Notch pathways are inherent signaling pathways in normal embryogenesis, devel...
Cancer stem cells (CSCs) are self-renewable cell types that are identified in most types of liquid a...
Cells with "stemness" and tumor-initiating properties have been isolated from both hematological and...
Cancer stem cells (CSCs) have provided new insights into the tumorigenesis and metastatic potential ...
Cancer stem cells (CSCs) are thought to be a distinct population of cells within a tumor mass that a...
Resistance to cancer therapy remains a significant obstacle in treating patients with various solid ...
The cellular heterogeneity of neoplasms has been at the center of considerable interest since the "c...
Many theories have been proposed to explain the origins of cancer. Currently, evidences show that no...
Many, if not all, tumours contain a sub-population of self-renewing and expanding stem cells known a...
Abstract Cancer stem cells (CSCs) are defined as a subpopulation of malignant tumor cells with selec...
Cancer stem cells (CSCs) were discovered about 15 years ago in hematopoietic cancers. Subsequently, ...
Cancer stem cells (CSCs) with therapeutic resistance and plasticity can be found in various types of...
Cancer stem cells are found in many cancer types. They comprise a distinct subpopulation of cells wi...
Cancer stem cells (CSCs) are gaining prominence in oncology. The characterization of the molecular p...
Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been considered ...